Evaluation of the risk of developing hepatocellular carcinoma in chronic Hepatitis C patients receiving antiviral treatment

Introduction: Chronic HC leads to the development of liver cirrhosis (LC) and hepatocellular carcinoma (HCC). The treatment of chronic HC with DAAs reduces mortality from LC and HCC. The study aimed to investigate the serological markers specific to HCC (PIVKA-II and AFP) in patients with chronic H...

Descripción completa

Detalles Bibliográficos

Autores principales:	Sona Sargsyan, Hripsime Magdesieva, Tsoghik Navoyan, Aregnaz Mkhitaryan, Lusine Atoyan, Violeta Sargsyan, Hayk Harutyunyan, Vahe Azatyan, Armine Minasyan, Naira Gyulazyan
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	The Journal of Infection in Developing Countries 2024-05-01
Colección:	Journal of Infection in Developing Countries
Materias:	Chronic HCV infection hepatocellular carcinoma liver cirrhosis direct-acting antiviral agents
Acceso en línea:	https://jidc.org/index.php/journal/article/view/18410
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!